GL1X · GenesisL1 explorer

Ligand · 4B8

4B8 · 2,6-dichloro-4-[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]phenol

4B8, 2,6-dichloro-4-[5-(4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]phenol (C14 H8 Cl2 N2 O3, 323.1 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues…

Component
4B8
Formula
C14 H8 Cl2 N2 O3
Class
ligand
Structures
2
PDB entries
1

Binding sites

4B8 in 2 structures; the first of them:

  • 4YDN · High resolution crystal structure of human transthyretin bound to ligand and conjugates… · 4B8 A202 · binds 4AK15, LEU17, GLU54, ALA108, LEU110, SER117, THR119
  • 4YDN · High resolution crystal structure of human transthyretin bound to ligand and conjugates… · 4B8 A202 · binds 4AK15, LEU17, GLU54, ALA108, LEU110, SER117, THR119

Residues it binds most

LEU 2, 4AK 2, ALA 2, GLU 2, SER 2, THR 2 (residue and the binding sites it lines).

Found with

  • 2WN · 4-[5-(3,5-dichloro-4-hydroxyphenyl)-1,3,4-oxadiazol-2-yl]phenyl sulfurofluoridate

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.